Schreiner MediPharm unveils freeze-light-protect syringe label

GERMANY – Munich-based provider of innovative functional label solutions for the healthcare industry, Schreiner MediPharm has introduced a new protective syringe label suitable for deep freeze applications.

According to Schreiner MediPharm, the Freeze-Light-Protect syringe label combines light protection with viability at temperatures well below zero.

The new solution is especially applicable to sensitive mRNA-based substances, as well as cell and gene therapies.

Therapies and vaccines with mRNA substances, as well as cell and gene therapies, are becoming increasingly prevalent.

These novel active ingredients entail special logistical challenges: For starters, they must be transported and stored on dry ice at freezing temperatures as low as -100 °C.

In addition, depending on the type of substance, special light protection is often necessary. For these specific applications, Schreiner MediPharm has developed the Freeze-Light-Protect syringe label.

Freeze-Light-Protect securely adheres to the syringe even in extremely low temperatures, ensuring reliable marking.

The specialty label can also be enhanced with various levels of UV and light protection. The first level exclusively provides UV protection, while the second level protects against both UV rays and blue light.

A third level provides comprehensive light protection. Light protection levels can be customized to meet the specific requirements of the active ingredient.

Additional integrated functionalities are also available, including detachable documentation labels for vaccination cards or patients’ medical records, inspection windows for checking syringe contents in unadulterated color, and graduations for correct dosing of injections.

The novel label from Schreiner MediPharm was developed in coordination with its partner SCHOTT Pharma, which launched the SCHOTT TOPPAC freeze syringe.

The 1 ml long COC syringe was developed for medicines with temperatures down to -100 °C, with a view to retaining the syringe’s functionality and integrity of the syringe closure, thus securing drug stability.

Schreiner MediPharm’s Freeze-Light-Protect was tested specifically for the SCHOTT TOPPAC freeze syringe to prove the reliability of the label-integrated protective functions and other features.

Thanks to the combination of the Freeze-Light-Protect label and SCHOTT TOPPAC freeze syringe, pharmaceutical companies can benefit from a pre-qualified solution customizable to corresponding applications.

Due to the combined expertise of Schreiner MediPharm and SCHOTT Pharma, they are optimally supported in bringing their deep-frozen drugs to the market.

For all the latest packaging and printing industry news from Africa and the World, subscribe to our NEWSLETTER, follow us on Twitter and LinkedIn, like us on Facebook, and subscribe to our YouTube channel.